Letter to the Editor: ABIDE in NAFLD: A Potential Game Changer in a Select Cohort of Cirrhosis.

We read with great interest the study published by Luis calzadilla-bertot et al.1 The study has proposed the ABIDE score which aims to predict decompensation in a selected cohort of NAFLD patients with cirrhosis which is a simple bedside tool. However, there are issues which need further clarification.